The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PIK3CA mutations are distinctive genetic features in non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD): A comprehensive mutational analysis from multi-institutional cohort.
 
Kenji Sawa
No Relationships to Disclose
 
Tomoya Kawaguchi
Honoraria - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; Ono Pharmaceutical
 
Yasuhiro Koh
Honoraria - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Illumina; Kyowa Hakko Kirin; Lilly; Ono Pharmaceutical; Raindance Technologies
Consulting or Advisory Role - Tosoh Corporation
Research Funding - Chugai Pharma; Daiichi Sankyo; Novartis
 
Satoshi Kambayashi
No Relationships to Disclose
 
Kazuhisa Asai
No Relationships to Disclose
 
Shigeki Mitsuoka
No Relationships to Disclose
 
Tatsuo Kimura
No Relationships to Disclose
 
Naruo Yoshimura
No Relationships to Disclose
 
Akihito Kubo
No Relationships to Disclose
 
Hideo Saka
No Relationships to Disclose
 
Akihide Matsumura
No Relationships to Disclose
 
Noritoshi Nishiyama
No Relationships to Disclose
 
Kazuto Hirata
No Relationships to Disclose